{"id":"https://openalex.org/W2379498189","doi":null,"title":"Incidence and Management of Hypertension Induced by Bevacizumab","display_name":"Incidence and Management of Hypertension Induced by Bevacizumab","alternate_titles":[],"publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2379498189","mag":"2379498189"},"language":"en","primary_location":{"id":"mag:2379498189","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=SYAZ201306017","pdf_url":null,"source":{"id":"https://openalex.org/S2764411740","display_name":"The Practical Journal of Cancer","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4324114251","host_organization_name":"Jiangxi Cancer Hospital","host_organization_lineage":["https://openalex.org/P4324114251"],"host_organization_lineage_names":["Jiangxi Cancer Hospital"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The Practical Journal of Cancer","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2379498189"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100421383","display_name":"Yang Li","orcid":"https://orcid.org/0000-0001-9612-2704","observed_orcids":["https://orcid.org/0000-0001-9612-2704"]},"institutions":[{"id":"https://openalex.org/I4210160344","display_name":"Tongji Hospital","ror":"https://ror.org/04xy45965","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210160344"]},{"id":"https://openalex.org/I47720641","display_name":"Huazhong University of Science and Technology","ror":"https://ror.org/00p991c53","country_code":"CN","type":"education","lineage":["https://openalex.org/I47720641"]}],"countries":["CN"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Yang Li","raw_affiliation_strings":["Department of Oncology,Tongji Hospital,Tongji Medical College, Huazhong University of Science and Technology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology,Tongji Hospital,Tongji Medical College, Huazhong University of Science and Technology","institution_ids":["https://openalex.org/I4210160344","https://openalex.org/I47720641"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5100421383"],"corresponding_institution_ids":["https://openalex.org/I4210160344","https://openalex.org/I47720641"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.43630000948905945,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.43630000948905945,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.20509999990463257,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.10300000011920929,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.996999979019165},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5249999761581421},{"id":"https://openalex.org/keywords/advanced-malignant-tumors","display_name":"advanced malignant tumors","score":0.8550000190734863},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.621999979019165},{"id":"https://openalex.org/keywords/incidence","display_name":"incidence","score":0.5479999780654907},{"id":"https://openalex.org/keywords/antihypertensive-therapy","display_name":"antihypertensive therapy","score":0.7940000295639038}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.9795210361480713},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9276179671287537},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.7481400966644287},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6344583630561829},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5734714865684509},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5504905581474304},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.436572790145874},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3645855486392975},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3352046012878418},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.1569310426712036},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2379498189","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=SYAZ201306017","pdf_url":null,"source":{"id":"https://openalex.org/S2764411740","display_name":"The Practical Journal of Cancer","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4324114251","host_organization_name":"Jiangxi Cancer Hospital","host_organization_lineage":["https://openalex.org/P4324114251"],"host_organization_lineage_names":["Jiangxi Cancer Hospital"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The Practical Journal of Cancer","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2242319010","https://openalex.org/W1994052042","https://openalex.org/W2243484597","https://openalex.org/W4315706067","https://openalex.org/W2472237999","https://openalex.org/W1977379029","https://openalex.org/W2277547567","https://openalex.org/W2359710392","https://openalex.org/W6906677649","https://openalex.org/W2750979344"],"abstract_inverted_index":{"Objective":[0],"To":[1],"investigate":[2],"the":[3,46,51,67,87],"incidence":[4,58,123],"and":[5,14,27,41,121],"management":[6,16],"of":[7,17,48,53,59,66,74,86,124,129,145],"hypertension":[8,54,61,73,126,141],"induced":[9],"by":[10],"bevacizumab.Methods":[11],"Blood":[12],"pressure":[13,85],"corresponding":[15,95],"53":[18,32,68],"patients":[19,36,89,117],"with":[20,25,39,109,119],"advanced":[21,33,114],"malignant":[22,34,115],"tumors":[23],"treated":[24,38,118],"bevacizumab":[26,40,49,120],"chemotherapy":[28],"were":[29,37,70],"retrospectively":[30],"analysed.Results":[31],"tumor":[35,116],"chemotherapy.The":[42],"median":[43],"time":[44],"from":[45],"initiation":[47],"to":[50,133,137,147],"beginning":[52],"was":[55,62,90,101],"46":[56],"days.The":[57],"treatment-induced":[60,125,140],"18.9%(10/53).And":[63],"3":[64],"out":[65],"patients(5.7%)":[69],"classified":[71],"as":[72],"grade":[75],"3\uff5e4.No":[76],"serious":[77],"cardiac":[78],"events":[79],"or":[80],"hypertensive":[81],"crisis":[82],"happened.The":[83],"blood":[84],"10":[88],"in":[91,105],"good":[92],"controll":[93],"after":[94],"treatment.Univariate":[96],"analysis":[97],"revealed":[98],"that":[99],"there":[100],"no":[102],"statistical":[103],"difference":[104],"clinical":[106],"outcome":[107],"stratified":[108],"bevacizumab-induced":[110],"hypertension(":[111],"P=0.707).Conclusion":[112],"In":[113],"chemotherapy,the":[122],"is":[127],"high.Most":[128],"them":[130],"are":[131],"mild":[132],"moderate,and":[134],"respond":[135],"well":[136],"proper":[138],"treatment.The":[139],"isn't":[142],"predictive":[143],"factor":[144],"response":[146],"bevacizumab.":[148]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2379498189","counts_by_year":[],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
